Meta-Analysis: Medications that Reduce or Increase the Risk of New Onset Diabetes
11 Aug, 2019 | 22:24h | UTC“α-Glucosidase inhibitors, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, metformin, orlistat, phentermine/topiramate, and pioglitazone significantly reduced the risk of biochemical conversion to T2DM, whereas statins and nateglinide increased the risk”